» Articles » PMID: 6206136

1,25-Dihydroxyvitamin D3 Inhibits Antigen-induced T Cell Activation

Overview
Journal J Immunol
Date 1984 Oct 1
PMID 6206136
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

The proliferative response of murine spleen and thymus cells to antigen but not to lectin was inhibited by the active metabolite of vitamin D3, 1,25-(OH)2D3. To directly examine the effect of 1,25-(OH)2D3 on T cell activation in the absence of other complicating interactions, we utilized a panel of cloned Ia-restricted T cell hybridomas that secrete IL 2 on activation by cloned Ia-bearing stimulator cells (TA3) or when stimulated by mitogen. Physiologic concentrations of 1,25-(OH)2D3 (0.01 to 0.1 nm) inhibited the antigen-induced secretion of IL 2 by several of these T cell hybridomas. This inhibition was dependent on the concentration of the free hormone and could be overcome by increasing the number of Ia-bearing stimulator cells used. Pretreatment of the T hybridoma but not the TA3 stimulator cell with 1,25-(OH)2D3 resulted in inhibition of activation. These results are consistent with the finding that specific 1,25-(OH)2D3 receptors are present on the T cell hybridomas but are lacking in TA3 cells. 1,25-(OH)2D3 failed, however, to inhibit the activation of the T cell hybridomas by lectin or by an anti-Thy-1 antibody. These findings suggest that 1,25-(OH)2D3 may be interfering with early events of antigen-induced T cell activation, perhaps by hindering T cell recognition of the relevant antigen on stimulator cell surfaces. This system should prove useful in studying the molecular mechanisms by which 1,25-(OH)2D3 acts to inhibit T cell activation and subsequent IL 2 production.

Citing Articles

Skewed epithelial cell differentiation and premature aging of the thymus in the absence of vitamin D signaling.

Artusa P, Nguyen Yamamoto L, Barbier C, Valbon S, Aghazadeh Habashi Y, Djambazian H Sci Adv. 2024; 10(39):eadm9582.

PMID: 39321290 PMC: 11423877. DOI: 10.1126/sciadv.adm9582.


A phase II dose evaluation pilot feasibility randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study).

OHearn K, Menon K, Weiler H, Amrein K, Fergusson D, Gunz A BMC Pediatr. 2023; 23(1):397.

PMID: 37580663 PMC: 10424361. DOI: 10.1186/s12887-023-04205-9.


Cutting Edge: Aire Is a Coactivator of the Vitamin D Receptor.

Artusa P, LeBel M, Barbier C, Memari B, Salehi-Tabar R, Karabatsos S J Immunol. 2023; 211(2):175-179.

PMID: 37265392 PMC: 10315440. DOI: 10.4049/jimmunol.2300207.


Cholecalciferol-load films for the treatment of nasal burns caused by cauterization of the hypertrophied inferior turbinate: formulation, in vivo study, and clinical assessment.

Mohamad S, Badwi A, Elrehany M, Ali S, Helmy A Drug Deliv Transl Res. 2022; 13(4):1102-1115.

PMID: 36509965 DOI: 10.1007/s13346-022-01275-7.


Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.

Li L, Liu T, Gu Y, Wang X, Xie R, Sun Y Front Immunol. 2022; 13:974305.

PMID: 36211363 PMC: 9539765. DOI: 10.3389/fimmu.2022.974305.